Uncategorized October 29, 20160Lattice Biologics Doubles Current Private Placement to $1.5M Lattice Biologics (TSX-V: LBL) (OTCBB: BLVKF) announced an increase in the size of its non-brokered…
October 4, 20100A Unique Roadblock for Pfizer’s Osteoarthritis Drug We’ve heard of drugs underperforming in clinical trials, but is it possible for a drug to over-perform?
